LCTX Lineage Cell Therapeutics, Inc.

AMEX
$0.80

Lineage Cell Therapeutics, Inc. (LCTX) Insider Activity

What the officers, directors and large holders did with their own shares. Only open-market purchases and sales count toward the totals — grants, option exercises and shares withheld for tax are compensation mechanics, not decisions, and they're listed separately below.

Insider signal Bullish Insiders bought more than they sold over this window — uncommon at any size.
Cluster activity 2 buyers in the last 30 days 2 buyers in the last 90 days 0 sellers in the last 90 days
Insiders buying
2
2 transactions
Insiders selling
0
0 transactions
Purchases
$54.2K
60,500 shares
Sales
$0
0 shares
Net activity
$54.2K
purchases less sales

Where they traded

Buy Sell Dot area is proportional to transaction value.

Last open-market purchase: November 16, 2026 , by Culley Brian M .

Recent open-market activity

Date Insider Role Action Shares Price Value Held after
Culley Brian M President and CEO Buy 40,500 $0.92 $37.1K 296,016
Howe Jill Ann Chief Financial Officer Buy 20,000 $0.85 $17.1K 45,500

Form 4s are due within two business days of a transaction, so this is close to real time — unlike the quarterly 13F data on the Institutional tab. A single large sale often reflects a prearranged 10b5-1 plan rather than a fresh view, so read a pattern of sales rather than any one of them.